Evaluation of gadobenate dimeglumine for contrast-enhanced MRI of the breast

American Journal of Roentgenology

Volumn 181, Issue 3, 2003, Pages 677-678

  Hylton, Nola M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE;

BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL;

EID: 0041508876     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.3.1810677     Document Type: Note

References (1)

1. Knopp MV, Bourne MW, Sardanelli F, et al. Gadobenate dimeglumine-enhanced MRI of the breast: analysis of dose response and comparison with gadopentetate dimeglumine. AJR 2003;181:663-676